Saxagliptin CAS 361442-04-8 Saxagliptin 15ND2 Diabetes API
Saxagliptin |
CAS No.: 361442-04-8 |
Purity:≥98% |
Molecular weight: 315.41 g/mol |
Molecular formula: C₁₈H₂₅N₃O₂ |
Appearance:White to white crystalline powder |
Package: 1g,10g,100g,1000g |
Saxagliptin CAS 361442-04-8 Saxagliptin 15ND2 Diabetes API
Color:white to off-white
Form:Solid
Stability:temperature Sensitive
Melting point:103-107℃
메시지
우리는 가능한 한 빨리 당신에게 답전을 드리겠습니다!
자기:,
저는 Saxagliptin CAS 361442-04-8 Saxagliptin 15ND2 Diabetes API에 관심이 있습니다. 당신은 저에게 더 많은 세부 사항을 보낼 수 있습니까? 예를 들면 유형, 사이즈, 최소 주문량, 재료 등입니다.
감사합니다.
답변을 기다리십시오.
Highlight: Saxagliptin Active Pharmaceutical Ingredient,361442-04-8 Active Pharmaceutical Ingredient,15ND2 saxagliptin
Saxagliptin CAS 361442-04-8 Saxagliptin 15ND2 Diabetes API
Description
Saxagliptin is an oral hypoglycemic drug of the dipeptidyl peptidase-4(DPP-4) inhibitor class, which sold under the brand name Obglyza. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug.
Basic parameters
Drug class | DPP-4 inhibitors |
Density | 1.35 |
Storage temp. | 2-8℃ |
Synonym | Saxagliptin 15ND2 |
Solubility | DMSO (Slightly), Methanol (Sparingly) |
HS Code | 29339900 |
Chemical Formula
What is the function of Saxagliptin?
It is a type 2 diabetes drug that can stimulate the pancreas to produce more insulin after the meal. Also it is a reversible, competitive dipeptidyl peptidase-4 inhibitor. Saxagliptin acts by preventing the degradation of glucagon-like peptide-1 and hence increases secretion of insulin and decreases secretion of glucagon.
Reference
https://www.ncbi.nlm.nih.gov>pmc
추천 상품